Merck (MRK) Reiterated at Buy by UBS: Bags FDA CNPV Voucher for Sac-TMT
Tweet Send to a Friend
UBS analyst Michael Yee reiterated a Buy rating and $130.00 price target on Merck (NYSE: MRK).The analyst commented, "Two key ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
